Endogenous nandrolone metabolites in human urine: preliminary results to discriminate between endogenous and exogenous origin

被引:44
作者
Le Bizec, B
Bryand, F
Gaudin, I
Monteau, F
Poulain, F
Andre, F
机构
[1] Ecole Natl Vet, LABERCA, F-44087 Nantes 03, France
[2] FCNA, Ctr Jose Arribas, F-44240 La Chapelle Sur Erdre, France
关键词
anabolic; nandrolone; doping; endogenous; 19-norandrosterone; conjugation; 19-noretiocholanolone;
D O I
10.1016/S0039-128X(01)00139-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When administered to human subjects, nandrolone is metabolized into two main products, 19-norandrosterone (19-NA) and 19-noretiocholanolone (19-NE). Recent studies demonstrated the endogenous production of these compounds in man at concentrations very close to the threshold of the International Olympic Committee (IOC), i.e. 2 ng/ml. Because the possibility of reaching or exceeding this fateful limit is difficult to exclude, a complementary biochemical parameter is necessary for the differentiation of endogenous 19-NA and 19-NE production from residues resulting, from nandrolone consumption. We measured the endogenous concentrations of 19-NA and 19-NE in 385 urine samples from professional football players, and we studied the phase II metabolite composition in individuals excreting the highest concentrations. The results showed that around 30% of endogenous 19-norandrosterone was sulfo-conjugated, whereas 100% of 19-norandrosterone was excreted conjugated to a glucuronic acid when nandrolone was administered. This significant qualitative difference, appears to be a promising complementary criterion to more definitively conclude about an athlete's culpability, especially when nandrolone metabolites are found in the low ng/ml range. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 13 条
[1]   Athletic drug testing: An analyst's view of science and the law [J].
Bowers, LD ;
Black, R ;
Borts, DJ .
THERAPEUTIC DRUG MONITORING, 2000, 22 (01) :98-102
[2]  
CIARDI M, 1998, RECENT ADV DOPING AN, V6, P97
[3]   Urinary excretion of 19-norandrosterone of endogenous origin in man: quantitative analysis by gas chromatography mass spectrometry [J].
Dehennin, L ;
Bonnaire, Y ;
Plou, P .
JOURNAL OF CHROMATOGRAPHY B, 1999, 721 (02) :301-307
[4]   Oral administration of dehydroepiandrosterone to healthy men:: Alteration of the urinary androgen profile and consequences for the detection of abuse in sport by gas chromatography mass spectrometry [J].
Dehennin, L ;
Ferry, M ;
Lafarge, P ;
Pérès, G ;
Lafarge, JP .
STEROIDS, 1998, 63 (02) :80-87
[5]  
GEYER H, 2000, RECENT ADV DOPING AN, V7, P71
[6]  
Kintz P, 1999, ACTA CLIN BELG, P68
[7]   Evidence for the presence of endogenous 19-norandrosterone in human urine [J].
Le Bizec, B ;
Monteau, F ;
Gaudin, I ;
André, F .
JOURNAL OF CHROMATOGRAPHY B, 1999, 723 (1-2) :157-172
[8]  
Le Bizec B, 2000, RAPID COMMUN MASS SP, V14, P1058, DOI 10.1002/1097-0231(20000630)14:12<1058::AID-RCM991>3.0.CO
[9]  
2-7
[10]  
LEBIZEC B, 2000, RECENT ADV DOPING AN, V7, P109